XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]            
Revenue, net
Operating expenses:            
Research and development 457,627 355,891 1,520,870 1,198,966 1,690,865 827,005
General and administrative 1,339,448 985,390 4,401,158 1,868,342 2,806,801 1,506,421
Total operating expenses 1,797,075 1,341,281 5,922,028 3,067,308 (4,497,666) (2,333,426)
Loss from operations (1,797,075) (1,341,281) (5,922,028) (3,067,308) (4,497,666) (2,333,426)
Other income (expense)            
Interest income (expense) 11,332 33 (1,334,612) 724 (166,746) 3,333
FMV gain (loss) adjustment for derivatives (635,283) 3,443,647    
Other 14,896 14,896    
Foreign exchange gain 8,007 8,007    
Write-off of fixed asset         (10,201)
Total Other Income (Expense) (601,048) 33 2,131,938 724    
Net loss $ (2,398,123) $ (1,341,248) $ (3,790,090) $ (3,066,584) $ (4,664,412) $ (2,340,294)
Net loss per share, basic and diluted $ (0.26) $ (0.27) $ (0.49) $ (0.62) $ (0.96) $ (0.55)
Weighted average shares used to compute net loss per share, basic and diluted 9,207,386 4,945,010 5,959,577 4,789,670 4,876,899 4,232,765
Other comprehensive loss            
Foreign currency translation $ (190,863) $ (190,863)    
Total Comprehensive Loss $ (2,588,986) $ (1,341,248) $ (3,980,953) $ (3,066,584)